ClinicalTrials.Veeva

Menu

Primary Liver Cancer Cohort of South China

H

Huilian Zhu

Status

Enrolling

Conditions

Primary Liver Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT03297255
SYS-2013

Details and patient eligibility

About

This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer. Basic informations and detailed diagnosis informations (AJCC/TNM stage, MELD score, Child-Pugh score, and BCLC stage) were collected by professional doctors. Clinical outcomes (death, recurrence, and metastasis) will be followed up every two years after therapy.

Full description

Primary liver cancer (PLC) is highly malignant with high mortality which is particularly popular in China. Many factors are believed to associate with the occurrence and prognosis of liver cancer. This longitudinal observational cohort study was designed to investigate factors that influencing the occurrence and long-term survival of patients with primary liver cancer.

Enrollment

4,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age 18-80 years
  • consistent with primary liver cancer diagnostic criteria
  • first diagnosis (from diagnosis to admission interval of less than a month)
  • did not do any treatment of liver cancer

Exclusion criteria

  • refused to participate in this study
  • suffering from more than two kinds of primary tumors

Trial contacts and locations

1

Loading...

Central trial contact

Fang Aiping; Zhu Huilian, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems